AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2012
Dec 28, 2012
30786_dirs_2012-12-28_dfa7dd9e-d99d-4d97-bf95-28ffaffd8ec9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2012-12-28
Reporting Person: GOETZ JOHN (Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-28 | Bio-Rad A Common Stock | M | 10000 | $35.50 | Acquired | 43139.4727 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-28 | Incentive Stock Option (right to buy) | $35.50 | M | 5615 | Disposed | 2013-02-05 | Bio-Rad A Common Stock (5615) | Direct |
| 2012-12-28 | Non-Qualified Stock Option (right to buy) | $35.50 | M | 4385 | Disposed | 2013-02-05 | Bio-Rad A Common Stock (4385) | Direct |
Footnotes
F1: The option vested in five equal annual installments beginning on February 5, 2004.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13